Gara Jalqabaatti › Kanisa Harkaa › Texas › Dallas
Qorannoo klinikaalii Kanisa Harkaa Dallas, TX keessatti
Qorannoo 19 Kanisa Harkaa f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UT Southwestern, Dallas
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Baylor Scott & White Health, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor, Scott and White Research Institute, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Mary Crowley Cancer Research, Dallas
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Dallas
- Research Site, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Mary Crowley Cancer Research, Dallas
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UT Southwestern Medical Center, Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Texas Oncology, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- fi 2 dabalataa
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Texas Oncology - DFW, Dallas
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Texas Oncology Dallas Methodist, Dallas
- Texas Oncology Dallas Medical City, Dallas
- Texas Oncology Dallas Presbyterian, Dallas
- fi 2 dabalataa
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Texas Southwestern Medical Center, Dallas
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- Baylor University Medical Center, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Namoota walitti qabaa jiraSadarkaa 1
- Dren Investigational Site, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Qorannoo Kanisa Harkaa magaalota biroo keessatti
- Houston, TXQorannoo 42
- Boston, MAQorannoo 32
- New York City, NYQorannoo 31
- Nashville, TNQorannoo 28
- Los Angeles, CAQorannoo 22
- Baldwin Park, CAQorannoo 22
- Arlington, VAQorannoo 20
- San Antonio, TXQorannoo 19
- Grand Rapids, MIQorannoo 18
- St. Louis, MOQorannoo 18
- Washington, DCQorannoo 16
- Detroit, MIQorannoo 16
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Kansara MetastatikiiQorannoo 42
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dukkana BladderQorannoo 27
- Dhibee QaraQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.